Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Schulze Muscular Dystrophy Ability Clinical Study

NCT05409079 is registered in ClinicalTrials.gov with AbiliTech Medical Inc. as lead sponsor.

NCT NCT05409079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05409079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Schulze Muscular Dystrophy Ability Clinical Study
Lead sponsor
AbiliTech Medical Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
May 26, 2022
Completion date
June 30, 2023
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

becker muscular dystrophy, cerebral palsy, duchenne muscular dystrophy, fshd, limb girdle muscular dystrophy, muscular dystrophies, spinal muscular atrophy